SiliconBeat

Qun Zhou was reappointed interim Chief Financial Officer at Vermillion, the Fremont company formerly known as Ciphergen Biosystems that develops medical diagnostic tests, to replace the previous interim CFO Richard Taylor, who had served in that function as a consultant to the company since August.

Taylor and Vermillion agreed not to renew his consulting agreement, which expired on November 26,  “by mutual consent.”

Zhou served as controller at Vermillion since February 2007, and served as its interim CFO from November 1, 2007 to August 26, 2008. Prior to joining the company, Zhou served as controller for ViOptix, a developer and manufacturer of oxygen measuring devices in the biotechnology industry, from May 2005 through February 2007. From April 2000 through May 2005, Ms. Zhou served in several capacities, including Business Unit Controller, with Philips Medical Systems, a global leader in the medical device and diagnostic industry.